Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer.

Andreas MarxLena KoopmannDoris HöflmayerFranziska BüscheckClaudia Hube-MaggStefan SteurerTill EichenauerTill S ClauditzWaldemar WilczakRonald SimonGuido SauterJakob R IzbickiHartwig HulandHans HeinzerMarkus GraefenAlexander HaeseThorsten SchlommChristian BernreutherPatrick LebokSarah Bonk

Published in: Cancer biology & medicine (2021)

These data identify reduced ANO7 protein expression as a strong and independent predictor of poor prognosis in PCa. ANO7 measurement, either alone or in combination, might provide clinically useful prognostic information in PCa.

Keyphrases

poor prognosis
prostate cancer
long non coding rna
radical prostatectomy
electronic health record
health information
healthcare